WEST PHARMACEUTICAL SERVICES, INC. Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax of $900.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for the quarter ending 2012-03-31 was $100.00K, a 50.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for the quarter ending 2011-03-31 was $200.00K.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2025 was $900.00K, a 200.00% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2024 was $300.00K, a 25.00% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2023 was $400.00K.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2022 was -$2.40M, a 214.29% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 3 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 12 month |
|---|---|---|
| 2025-12-31 | $900.00K 10-K · filed 2026-02-17 | |
| 2024-12-31 | $300.00K 10-K · filed 2026-02-17 | |
| 2023-12-31 | $400.00K 10-K · filed 2026-02-17 | |
| 2022-12-31 | -$2.40M 10-K · filed 2025-02-18 | |
| 2021-12-31 | $2.10M 10-K · filed 2024-02-20 | |
| 2020-12-31 | -$700.00K 10-K · filed 2023-02-21 | |
| 2019-12-31 | -$300.00K 10-K · filed 2022-02-22 | |
| 2018-12-31 | -$200.00K 10-K · filed 2021-02-23 | |
| 2017-12-31 | $1.30M 10-K · filed 2020-02-24 | |
| 2016-12-31 | -$4.80M 10-K · filed 2019-02-28 | |
| 2015-12-31 | -$6.00M 10-K · filed 2018-02-26 | |
| 2014-12-31 | -$10.60M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $20.30M 10-K · filed 2016-02-26 | |
| 2012-12-31 | -$6.20M 10-K · filed 2015-02-25 | |
| 2012-03-31 | $100.00K 10-Q · filed 2012-05-04 | |
| 2011-12-31 | -$17.90M 10-K · filed 2014-02-27 | |
| 2011-03-31 | $200.00K 10-Q · filed 2012-05-04 | |
| 2010-12-31 | -$2.60M 10-K · filed 2013-02-27 | |
| 2009-12-31 | -$1.10M 10-K/A · filed 2012-03-01 | |
| 2008-12-31 | -$21.60M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |